EVNIN ANTHONY B

Director at RENOVIS INC · on record since Jan 17, 2006
Director at Viracta Therapeutics, Inc. · on record since Jun 22, 2006
10% owner at MEMORY PHARMACEUTICALS CORP · on record since Apr 5, 2004
Director at MEMORY PHARMACEUTICALS CORP · on record since Jul 21, 2006
Director at INFINITY PHARMACEUTICALS, INC. · on record since Sep 14, 2006
Director at PHARMOS CORP · on record since Oct 27, 2006
Director at ICAGEN INC · on record since Feb 8, 2007
10% owner at PHARMOS CORP · on record since Apr 23, 2009
Director at AVEO PHARMACEUTICALS, INC. · on record since Mar 18, 2010
Director at ACCELERON PHARMA INC · on record since Sep 26, 2013
10% owner at ACCELERON PHARMA INC · on record since Sep 25, 2013
10% owner at RENOVIS INC · on record since Feb 4, 2004
Director at OTIX GLOBAL, INC. · on record since Feb 4, 2004
10% owner at OTIX GLOBAL, INC. · on record since Feb 4, 2004
Director at Juno Therapeutics, Inc. · on record since Dec 23, 2014
Director at CRITICARE SYSTEMS INC /DE/ · on record since Jan 19, 2017
10% owner at ICAGEN INC · on record since Feb 3, 2005
Director at CONSTELLATION PHARMACEUTICALS INC · on record since Jul 23, 2018
10% owner at · on record since Jul 23, 2018
Director at · on record since Aug 10, 2005
10% owner at · on record since Aug 10, 2005

Insider trading activity of EVNIN ANTHONY B

Transactions on record: 356; since Feb 12, 2004

Open-market buys: 23; $46.3M

Open-market sells: 31; $76.7M

Companies traded: 13; last filing Jan 19, 2023

Figures computed from official regulatory filings — .

Companies where EVNIN ANTHONY B has traded

49 tx · $3M · Jan 19, 2023
59 tx · $5.2M · Jun 16, 2022
10 tx · $1.4M · Jun 2, 2021
11 tx · $39.8M · Dec 16, 2019
44 tx · $72.1M · Mar 7, 2018
13 tx · Dec 9, 2013
24 tx · $90.6K · Jul 3, 2012
23 tx · $3.6M · Sep 7, 2011
23 tx · $945K · Apr 7, 2009
38 tx · $3.3M · Jan 6, 2009
30 tx · May 7, 2008
12 tx · Aug 16, 2005
20 tx · $76.9K · May 7, 2004

Track record of EVNIN ANTHONY B

Open-market buys: 40

Last buy: Mar 26, 2020

Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.

Transaction history of EVNIN ANTHONY B

Co-insiders of EVNIN ANTHONY B

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
AVEO PHARMACEUTICALS, INC.Listing unverified	Jan 19, 2023	OtherD (derivative)	-1,250	—	n/a (No price was disclosed in the filing)		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jan 19, 2023	OtherD (derivative)	-2,000	—	n/a (No price was disclosed in the filing)		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jan 19, 2023	OtherD (derivative)	-1,250	—	n/a (No price was disclosed in the filing)		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jan 19, 2023	OtherD (derivative)	-7,785	—	n/a (No price was disclosed in the filing)		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jan 19, 2023	OtherD (derivative)	-6,402	—	n/a (No price was disclosed in the filing)		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jan 19, 2023	Other	-41,841	15.00 USD	$627.6K		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jan 19, 2023	OtherD (derivative)	-4,000	—	n/a (No price was disclosed in the filing)		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jan 19, 2023	OtherD (derivative)	-4,000	—	n/a (No price was disclosed in the filing)		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jan 19, 2023	OtherD (derivative)	-12,500	—	n/a (No price was disclosed in the filing)		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jan 19, 2023	OtherD (derivative)	-22,500	—	n/a (No price was disclosed in the filing)		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jan 19, 2023	OtherD (derivative)	-4,000	—	n/a (No price was disclosed in the filing)		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jan 19, 2023	OtherD (derivative)	-2,515	—	n/a (No price was disclosed in the filing)		SEC
INFINITY PHARMACEUTICALS, INC.Listing unverified	Jun 16, 2022	AwardD (derivative)	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
INFINITY PHARMACEUTICALS, INC.Listing unverified	Jun 16, 2022	Award	46,378	0.68 USD	$31.5K	Unusual size	SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jun 8, 2022	AwardD (derivative)	22,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
INFINITY PHARMACEUTICALS, INC.Listing unverified	Jun 11, 2021	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
INFINITY PHARMACEUTICALS, INC.Listing unverified	Jun 11, 2021	Award	3,061	3.43 USD	$10.5K		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jun 9, 2021	AwardD (derivative)	12,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CRITICARE SYSTEMS INC /DE/Listing unverified	Jun 2, 2021	Other	-12,132	80.59 USD	$977.7K		SEC
CRITICARE SYSTEMS INC /DE/Listing unverified	Jul 31, 2020	Award	1,935	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jun 30, 2020	AwardD (derivative)	4,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
INFINITY PHARMACEUTICALS, INC.Listing unverified	Jun 18, 2020	Award	22,826	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
INFINITY PHARMACEUTICALS, INC.Listing unverified	Jun 18, 2020	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CRITICARE SYSTEMS INC /DE/Listing unverified	Mar 27, 2020	Buy	1,300	37.40 USD	$48.6K	conv 37Cluster	SEC
CRITICARE SYSTEMS INC /DE/Listing unverified	Mar 27, 2020	Buy	1,200	40.37 USD	$48.4K	conv 37Cluster	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
AVEO PHARMACEUTICALS, INC.Listing unverified	Jan 19, 2023	OtherD (derivative)	-1,250	—	n/a (No price was disclosed in the filing)		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jan 19, 2023	OtherD (derivative)	-2,000	—	n/a (No price was disclosed in the filing)		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jan 19, 2023	OtherD (derivative)	-1,250	—	n/a (No price was disclosed in the filing)		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jan 19, 2023	OtherD (derivative)	-7,785	—	n/a (No price was disclosed in the filing)		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jan 19, 2023	OtherD (derivative)	-6,402	—	n/a (No price was disclosed in the filing)		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jan 19, 2023	Other	-41,841	15.00 USD	$627.6K		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jan 19, 2023	OtherD (derivative)	-4,000	—	n/a (No price was disclosed in the filing)		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jan 19, 2023	OtherD (derivative)	-4,000	—	n/a (No price was disclosed in the filing)		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jan 19, 2023	OtherD (derivative)	-12,500	—	n/a (No price was disclosed in the filing)		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jan 19, 2023	OtherD (derivative)	-22,500	—	n/a (No price was disclosed in the filing)		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jan 19, 2023	OtherD (derivative)	-4,000	—	n/a (No price was disclosed in the filing)		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jan 19, 2023	OtherD (derivative)	-2,515	—	n/a (No price was disclosed in the filing)		SEC
INFINITY PHARMACEUTICALS, INC.Listing unverified	Jun 16, 2022	AwardD (derivative)	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
INFINITY PHARMACEUTICALS, INC.Listing unverified	Jun 16, 2022	Award	46,378	0.68 USD	$31.5K	Unusual size	SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jun 8, 2022	AwardD (derivative)	22,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
INFINITY PHARMACEUTICALS, INC.Listing unverified	Jun 11, 2021	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
INFINITY PHARMACEUTICALS, INC.Listing unverified	Jun 11, 2021	Award	3,061	3.43 USD	$10.5K		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jun 9, 2021	AwardD (derivative)	12,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CRITICARE SYSTEMS INC /DE/Listing unverified	Jun 2, 2021	Other	-12,132	80.59 USD	$977.7K		SEC
CRITICARE SYSTEMS INC /DE/Listing unverified	Jul 31, 2020	Award	1,935	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
AVEO PHARMACEUTICALS, INC.Listing unverified	Jun 30, 2020	AwardD (derivative)	4,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
INFINITY PHARMACEUTICALS, INC.Listing unverified	Jun 18, 2020	Award	22,826	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
INFINITY PHARMACEUTICALS, INC.Listing unverified	Jun 18, 2020	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CRITICARE SYSTEMS INC /DE/Listing unverified	Mar 27, 2020	Buy	1,300	37.40 USD	$48.6K	conv 37Cluster	SEC
CRITICARE SYSTEMS INC /DE/Listing unverified	Mar 27, 2020	Buy	1,200	40.37 USD	$48.4K	conv 37Cluster	SEC